Karyopharm Reports Second Quarter 2017 Financial Results and Highlights Recent Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. BAC

Go back to Karyopharm Reports Second Quarter 2017 Financial Results and Highlights Recent Progress

Karyopharm Therapeutics (KPTI) Tops Q2 EPS by 1c

August 8, 2017 7:15 AM EDT

Karyopharm Therapeutics (NASDAQ: KPTI) reported Q2 EPS of ($0.64), $0.01 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Karyopharm Therapeutics (KPTI) click here.

... More